QardioMD Software solution for remote ECG monitoring

QardioMD Software solution for remote ECG monitoring

Free Delivery from €100 (EU)
Trusted Shop Warranty Certified Partner

Worldwide Shipping
Secure Shopping with secure SSL connection

SKU: 1905

Manufacturer: Qardio

MPN:

EAN: 4260497574873

Category: New products

Currently out of stock

€ 719,00

incl. 19% VAT ,

Choose tax zone / country of delivery

Qardio MD is a software solution for professional remote ECG and vital signs monitoring. It enables mobile remote monitoring of ECG and vital signs data for the early detection of heart disease in clients. The software offers a comprehensive dashboard for monitoring client data and includes a 12-month licence per user account. Note: The QardioCore ECG devices must be purchased separately or are available as a set here.

QardioMD - ECG remote monitoring for clients

QardioCore - The wireless ECG monitor without patch

QardioMD: Software solution for remote ECG monitoring

QardioMD is a sophisticated software solution designed specifically for use in professional settings such as medical practices, clinics and care homes. This platform enables healthcare professionals to monitor their clients' ECG and vital signs remotely. By integrating with Qardio devices, specifically the QardioCore ECG monitor, QardioMD provides seamless collection and analysis of ECG data as well as other vital health parameters. The software utilises advanced algorithms and artificial intelligence to ensure comprehensive analysis of the collected data, providing doctors and nurses with valuable insights into the health status of their clients.

A key feature of QardioMD is the clear and user-friendly dashboard, which enables effective management and monitoring of patient data. The dashboard provides a clear visualisation of collected vital signs, including ECG recordings, heart rate and heart rate variability. This makes it easier for medical staff to keep track of their patients' health status and respond promptly to changes.

QardioMD also has an intelligent alert system that automatically informs healthcare professionals of significant deviations or potential health risks. This system uses the Visensia Index, an innovative technology for individual risk assessment based on the analysis of several vital parameters. This enables early detection of heart problems and other health anomalies, allowing medical staff to respond quickly and in a targeted manner.

Advantages:

Enables continuous ECG monitoring and vital signs Analysis
AI-supported evaluation for precise findings
Visensia index for individual risk assessment
Supports remote monitoring for efficient client care
Real-time data transmission and analysis for arrhythmia detection

Scope of delivery:

Access to QardioMD software (12 month licence per patient and device)
Software package without hardware
Access via the Qardio Website

Technical Information:

Compatible with Apple iOS devices only
Integration with QardioCore devices for ECG data
Advanced AI-based data analysis
Visensia index for personalised risk assessment

Note:
QardioMD is intended as a support tool for healthcare professionals and does not replace personalised diagnosis or treatment by a physician. Consultation with a medical specialist is recommended for any questions or concerns. QardioCore devices for ECG monitoring are available separately.

Product Type:	Electrocardiogram - ECG
Applications:	Biofeedback Fitness Telehealth
Target Groups:	Professional Therapist Physicians Hospital usages Medical Practices
Product features:	ECG Sensor Multichannel sensor HRV Sensor

How can I use this additional power of the Qardio MD?

After you, as an end user, have purchased the hardware QardioCore, Qardio provides you with a corresponding platform in German language, you have to register on the platform, whereby the measurements are carried out customer-specifically. Qardio monitors these data and reports back.

If you are encouraged by your doctor or a hospital to use a QardioCore, the hardware is purchased by the hospital, which also registers the patient on the platform. The measurements are performed permanently and are accompanied by a physician. The data goes to the Qardio platform and returnes to the doctor/patient within an individually defined time period.

Is there any documentation on the authorisation of this screening method?

The indicator is FDA and CE approved, has been tested in 100's of thousands of patients. This is an addition to the QardioMD, which allow us to measure HR,RR and Temp just from the QardioCore, we have an index which then warns the doctor 6 hours before the patient needs urgent attention. This means instead of bringing all patients to the hospital, we can set up monitoring in their home.

There are no reviews yet.

Customers will be sent a link to rate the products. This is a personalized link only given to consumers who have actually purchased the goods or services from us.

Contact data

First name

Last name - optional

E-Mail